2-[2-(9,10-diphenylanthracen-2-yl)ethenyl]-1,10-phenanthroline
C40H26N2 — CID 91352751
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[2-(9,10-diphenylanthracen-2-yl)ethenyl]-1,10-phenanthroline
2-[2-(9,10-diphenylanthracen-2-yl)ethenyl]-1,10-phenanthroline (PubChem CID 91352751) has the molecular formula C40H26N2 and a molecular weight of 534.66 g/mol. Its IUPAC name is 2-[2-(9,10-diphenylanthracen-2-yl)ethenyl]-1,10-phenanthroline.
Molecular Properties
| Compound Name | 2-[2-(9,10-diphenylanthracen-2-yl)ethenyl]-1,10-phenanthroline |
|---|---|
| PubChem CID | 91352751 |
| Molecular Formula | C40H26N2 |
| Molecular Weight | 534.66 g/mol |
| Exact Mass | 534.21 |
| IUPAC Name | 2-[2-(9,10-diphenylanthracen-2-yl)ethenyl]-1,10-phenanthroline |
| SMILES | C(=Cc1ccc2ccc3cccnc3c2n1)c1ccc2c(-c3ccccc3)c3ccccc3c(-c3ccccc3)c2c1 |
| InChI | InChI=1S/C40H26N2/c1-3-10-28(11-4-1)37-33-15-7-8-16-34(33)38(29-12-5-2-6-13-29)36-26-27(18-24-35(36)37)17-22-32-23-21-31-20-19-30-14-9-25-41-39(30)40(31)42-32/h1-26H |
| InChIKey | NDDURVHEGCHKLQ-UHFFFAOYSA-N |
| XLogP | 10.59 |
| TPSA | 25.78 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 42 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 534.66 |
| LogP ≤ 5 | 10.59 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 2 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Polycyclic_aromatic_hydrocarbon_2', 'substructure': 'N/A'}, {'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 91352751 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.